XML 71 R47.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (Details) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Condensed Financial Information [Line Items]    
Payments for (Proceeds from) Other Investing Activities $ 3,609 $ 3,490
Net cash (used) provided by operating activities 174,460 81,111
Investing Activities:    
Capital expenditures (23,749) (15,970)
Net cash used in investing activities (20,140) (12,480)
Financing Activities:    
Payments for Repurchase of Common Stock (27,055) (106,702)
Proceeds from (Payments for) Other Financing Activities (8,301) (4,380)
Net cash used in financing activities (124,820) (92,164)
Effect of exchange rate changes on cash and cash equivalents (4,693) 7,485
Net change in cash and cash equivalents 24,807 (16,048)
Cash and cash equivalents at the beginning of period 117,953 110,131
Cash and cash equivalents at the end of period 142,760 94,083
Parent Company [Member]    
Condensed Financial Information [Line Items]    
Payments for (Proceeds from) Other Investing Activities 0 0
Net cash (used) provided by operating activities 14,198 (28,740)
Investing Activities:    
Capital expenditures 0 0
Proceeds from Dividends Received 0 0
Net cash used in investing activities 0 0
Financing Activities:    
Borrowings 12,857 135,442
Repayments 0 0
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees 0 0
Payments for Repurchase of Common Stock (27,055) 106,702
Proceeds from (Payments for) Other Financing Activities 0 0
Net cash used in financing activities (14,198) 28,740
Effect of exchange rate changes on cash and cash equivalents 0 0
Net change in cash and cash equivalents 0 0
Cash and cash equivalents at the beginning of period 0 0
Cash and cash equivalents at the end of period 0 0
Guarantor Subsidiaries [Member]    
Condensed Financial Information [Line Items]    
Payments for (Proceeds from) Other Investing Activities (81,128) (174,032)
Net cash (used) provided by operating activities 62,439 168,603
Investing Activities:    
Capital expenditures (12,831) (7,435)
Proceeds from Dividends Received 118,271 51,561
Net cash used in investing activities 24,312 (129,906)
Financing Activities:    
Borrowings 246,323 557,391
Repayments (318,323) (587,485)
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees 0 0
Payments for Repurchase of Common Stock   0
Payments for Repurchase of Private Placement 0  
Proceeds from (Payments for) Other Financing Activities (8,301) (4,380)
Net cash used in financing activities (80,301) (34,474)
Effect of exchange rate changes on cash and cash equivalents 0 0
Net change in cash and cash equivalents 6,450 4,223
Cash and cash equivalents at the beginning of period 50,602 41,552
Cash and cash equivalents at the end of period 57,052 45,775
Non-Guarantor Subsidiaries [Member]    
Condensed Financial Information [Line Items]    
Payments for (Proceeds from) Other Investing Activities 3,609 16,711
Net cash (used) provided by operating activities 97,823 (58,752)
Investing Activities:    
Capital expenditures (10,918) (8,535)
Proceeds from Dividends Received 0 0
Net cash used in investing activities (7,309) 8,176
Financing Activities:    
Borrowings 933,046 691,682
Repayments (882,239) (617,301)
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees (118,271) (51,561)
Payments for Repurchase of Common Stock 0 0
Proceeds from (Payments for) Other Financing Activities 0 0
Net cash used in financing activities (67,464) 22,820
Effect of exchange rate changes on cash and cash equivalents (4,693) 7,485
Net change in cash and cash equivalents 18,357 (20,271)
Cash and cash equivalents at the beginning of period 67,351 68,579
Cash and cash equivalents at the end of period 85,708 48,308
Consolidated Entities [Member]    
Condensed Financial Information [Line Items]    
Payments for (Proceeds from) Other Investing Activities 3,609 3,490
Net cash (used) provided by operating activities 174,460 81,111
Investing Activities:    
Capital expenditures (23,749) (15,970)
Proceeds from Dividends Received 0 0
Net cash used in investing activities (20,140) (12,480)
Financing Activities:    
Borrowings 1,111,098 1,210,608
Repayments (1,200,562) (1,191,690)
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees 0 0
Payments for Repurchase of Common Stock 27,055 106,702
Proceeds from (Payments for) Other Financing Activities (8,301) (4,380)
Net cash used in financing activities (124,820) (92,164)
Effect of exchange rate changes on cash and cash equivalents (4,693) 7,485
Net change in cash and cash equivalents 24,807 (16,048)
Cash and cash equivalents at the beginning of period 117,953 110,131
Cash and cash equivalents at the end of period 142,760 94,083
Consolidation, Eliminations [Member]    
Condensed Financial Information [Line Items]    
Payments for (Proceeds from) Other Investing Activities 81,128 160,811
Net cash (used) provided by operating activities 0 0
Investing Activities:    
Capital expenditures 0 0
Proceeds from Dividends Received (118,271) (51,561)
Net cash used in investing activities (37,143) 109,250
Financing Activities:    
Borrowings (81,128) (173,907)
Repayments 0 (13,096)
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees (118,271) (51,561)
Payments for Repurchase of Common Stock 0 0
Proceeds from (Payments for) Other Financing Activities 0 0
Net cash used in financing activities 37,143 (109,250)
Effect of exchange rate changes on cash and cash equivalents 0 0
Net change in cash and cash equivalents 0 0
Cash and cash equivalents at the beginning of period 0 0
Cash and cash equivalents at the end of period $ 0 $ 0